Helene Sou is a Director in Global Regulatory Policy and Innovation in Takeda. She is focused on the Growth and Emerging Markets region and is based in Singapore.
Helene has 20 years of experience in international regulatory affairs gained through country, regional and global regulatory roles.
In the early part of her career, Helene worked as an EU Regulatory Consultant at Voisin Consulting Life Sciences in Paris, France before expanding her focus to International Regulatory Affairs in Boston, USA. Then, in Shire Human Genetic Therapies, Helene held several regional RA positions in Asia-Pacific. In Takeda, Helene was a Global Regulatory Lead for plasma-derived therapies, then acted as the Regulatory Liaison for the Emerging Markets.
Currently, she participates in various industry task forces, including the IFPMA Regulatory Reliance Task Force, EFPIA-ASEAN, Korea-Taiwan and India networks and Accumulus Synergy International Policy subcommittee. Helene co-chairs the Program Committee of DIA Singapore Annual Meeting.
Helene holds a Master of Sciences degree in Biotechnology and Management from the ESIEE-Management school in Paris.
